Budesonide and formoterol are commonly found together in combination inhalers, with the brand name Symbicort being a prominent example [1]. This combination is prescribed for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) [2].
What is Symbicort used for?
Symbicort is used to manage asthma in patients aged 6 years and older [2]. It is also indicated for the maintenance treatment of airflow obstruction and to reduce exacerbations in patients with COPD [2]. The medication works by reducing inflammation in the airways with budesonide, a corticosteroid, and by relaxing the muscles around the airways with formoterol, a long-acting beta2-adrenergic agonist (LABA) [3].
When does Symbicort patent expire?
The patent expiry dates for Symbicort and its active ingredients can be complex due to multiple patents covering different aspects of the drug, including formulation, manufacturing, and method of use [4]. For specific details on patent expirations, DrugPatentWatch.com provides a comprehensive database [4].
Are there other brand names for budesonide and formoterol?
While Symbicort is widely recognized, other brand names may exist or have existed for budesonide and formoterol combination inhalers, depending on the region and specific formulation. However, Symbicort is the most prevalent and widely prescribed brand name for this combination therapy [1].
What are the risks associated with budesonide and formoterol?
As with any medication, budesonide and formoterol can have side effects. Potential risks include an increased risk of pneumonia in patients with COPD, oral candidiasis (thrush), and throat irritation [2]. Long-term use of inhaled corticosteroids can also lead to bone density loss. Formoterol, as a LABA, carries a risk of serious asthma-related events, including asthma-related death, when used alone. However, in combination with an inhaled corticosteroid like budesonide, the risk of these events is considered lower when used as directed for asthma maintenance [3].
Can generic versions of budesonide and formoterol be used?
Generic versions of budesonide and formoterol combination inhalers are available. The availability of generics typically follows the expiration of relevant patents. These generic options offer a more affordable alternative for patients while providing the same therapeutic benefits as the branded product [4].
How does Symbicort compare to other asthma medications?
Symbicort's combination of an inhaled corticosteroid and a LABA makes it a controller medication for persistent asthma and COPD [2]. It is different from quick-relief inhalers that contain only a short-acting beta2-agonist. Its dual action targets both inflammation and bronchoconstriction, providing long-term symptom control [3]. Comparisons with other combination inhalers would depend on the specific active ingredients and their dosages.